paperBiotech

Diagnostic infrastructuring: Biomarkers, pharmaceutical marketing and governance in Taiwan

Diagnostic infrastructuring: Biomarkers, pharmaceutical marketing and governance in Taiwan

publishedDate Venue Social Science & Medicine

Source-permitted summary

Diagnostic infrastructuring: Biomarkers, pharmaceutical marketing and governance in Taiwan

SourceElsevier BV

AI Reading Notes

Core signal

Structured notes generated from source-linked AISci metadata. Treat them as a reading aid, not a substitute for the paper.

Core signal
Diagnostic infrastructuring: Biomarkers, pharmaceutical marketing and governance in Taiwan
Field context
Diagnostics and Biomarkers
People and labs
Not stated in the reviewed source.
Why it matters
Recent source-backed research output for AISci Stage A browsing.
Limits to check
AISci rank score does not assess scientific quality or citation impact.

Publication facts

Date
Jul 9, 2026SourceElsevier BV
Venue
Social Science & MedicineSourceElsevier BV
Open access
unknownSourceElsevier BV

External IDs

Author order

No reviewed author edge is attached to this output.

Organizations

No source-confirmed author affiliation is attached.

Related events

Topics

Relationship evidence

Timeline

  1. paperDiagnostic infrastructuring: Biomarkers, pharmaceutical marketing and governance in Taiwan